Office of Public Relations — Newsroom
News Release
Broncos Linebacker to Attend Free Prostate Cancer Screening Clinic at UCCC
(Photo and Interview Opportunities Available)
AURORA, Colo. (Sept. 19, 2005) — Denver Broncos linebacker Al Wilson is scheduled to appear at the Anschutz Cancer Pavilion at 2:30 p.m. Tuesday, Sept. 20 to help promote the importance of prostate cancer screening. Wilson, whose grandfather died of prostate cancer, is working with the Prostate Cancer Education Council (PCEC) and the National Football League to improve awareness of prostate cancer and the importance of annual screenings.
When it is caught early, prostate cancer is nearly 100 percent curable. Regular screenings are the key to detecting prostate cancer in its earliest stages. In recognition of National Prostate Cancer Awareness Week, the University of Colorado Cancer Center is offering free prostate cancer screenings Sept. 19-22 at the Anschutz Cancer Pavilion.
The Prostate Cancer Education Council (PCEC), a national organization created to improve the detection and treatment of prostate cancer, recommends that all men 40 and older be screened annually. Anyone with a family history of prostate cancer or those who belong to certain ethnic groups shown to be at a higher risk for contracting the disease, including African Americans and Hispanics, should begin annual screenings when they are 35.
"Research shows that deaths from prostate cancer nationwide have decreased due to prostate screenings and better treatments," said Dr. E. David Crawford, professor of urologic oncology at the University of Colorado at Denver and Health Sciences Center and chairman of the PCEC.
Last year during Prostate Cancer Awareness Week, UCCC screened more than 1,400 men, making it the largest free prostate cancer screening site in the Rocky Mountain region. The screenings last approximately 15 minutes and include a digital rectal examination (DRE) and a blood test to measure prostate specific antigen (PSA) levels. PSA is a protein that is secreted by the prostate, and elevated levels may indicate that prostate cancer is present.
Although recent research has shown that an elevated PSA may be less of a concern for some men than doctors originally thought, Crawford explained that it is important for men to participate in annual screenings to monitor any changes in their PSA levels.
"Through regular screenings, we can determine the baseline for different individuals," he said. "When we find elevated PSA levels or changes in PSA levels, additional testing is done to give the patient the information he needs to work with his physician to determine what, if any, further action is needed."
No appointment is needed for the screenings. Screenings will be offered 8 a.m. - 4 p.m. Monday, Sept. 19 through Thursday, Sept. 22 at the Anschutz Cancer Pavilion, 1665 N. Ursula in Aurora. Call (720) 848-0204 for more information.
The University of Colorado Cancer Center is the only National Cancer Institute-designated comprehensive cancer center in the Rocky Mountain Region. Headquartered primarily at the University of Colorado at Denver and Health Sciences Center, its four-part mission is excellence in cancer research, treatment, prevention and education. For more information, visit the Web site at www.uccc.info.